BioCatalyst

BMS-986165 — catalyst calendar

1 verified catalyst event(s) referencing BMS-986165, each linked to its official source. Verified as of 2026-08-06.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-12-01
in 4mo
ESTIMATED
 READOUT
A Study to Continue the Administration of Deucravacitinib in Participants With S
Phase 4 · Systemic Lupus Erythematosus (SLE), Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE)
 BMY BRISTOL MYERS SQUIBB CO BMS-986165 ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.